Veterinary Medicines

IZOVAC FOWL POX Liofilizzato e diluente per sospensione per puntura alare per polli

Authorised
  • Fowlpox virus, strain Brescia P1, Live
Download as PDF

Product identification

Medicine name:
IZOVAC FOWL POX Liofilizzato e diluente per sospensione per puntura alare per polli
Active substance:
  • Fowlpox virus, strain Brescia P1, Live
Target species:
  • Chicken
Route of administration:
  • Wing-web-stab use

Product details

Active substance and strength:
  • Fowlpox virus, strain Brescia P1, Live
    10000.00
    50% cell culture infectious dose
    /
    0.01
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Wing-web-stab use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD12
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Izo S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Izo S.r.l.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 14/08/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."